Xarelto Full Prescribing Information, Dosage & Side Effects | MIMS Hong Kong
Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation - ScienceDirect
Anticoagulation for Mechanical Heart Valves | Arteriosclerosis, Thrombosis, and Vascular Biology
AHA 2020: Rivaroxaban comparable to warfarin for patients with atrial fibrillation and prosthetic valves - Cardiovascular News
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
Rivaroxaban in patients with mechanical heart valves: A pilot study - Thrombosis Research
RIVERtrial - Twitter Search / Twitter
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves | 2 Minute Medicine
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial - ScienceDirect
A controlled trial of rivaroxaban after transcatheter aortic-valve replacement (GALILEO)
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
Warfarin in patients with mechanical heart valves | The BMJ
PDF) RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH MECHANICAL HEART VALVE: PRELIMINARY RESULTS
RIVER Trial Presented at #AHA20 / Twitter
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study. - Abstract - Europe PMC
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study | SpringerLink
Antithrombotic Therapy in Patients With Valvular Heart Disease
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements | Semantic Scholar
Usefulness and Safety of Rivaroxaban in Patients Following Isolated Mitral Valve Replacement With a Mechanical Prosthesis - ScienceDirect
Rivaroxaban noninferior to warfarin in patients with AF, bioprosthetic mitral valve: RIVER
